Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment

Clinical trial NCT03623347 · COMPLETED

Trial details

NCT number: NCT03623347
Sponsor: Centre Hospitalier Universitaire, Amiens
Status: COMPLETED
Study type: OBSERVATIONAL

Chemoradiotherapy

Start date: 2011-01-01
Primary completion: 2017-05-12
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.